Stanley N. Lapidus's most recent trade in Lucid Diagnostics Inc was a trade of 112,800 Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lucid Diagnostics Inc | Stanley N. Lapidus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 214,392 | - | 0 | Common Stock | |
| Lucid Diagnostics Inc | Stanley Lapidus N. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 150,000 | 150,000 | - | - | Employee stock option (right to buy) | |
| Lucid Diagnostics Inc | Stanley N. Lapidus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 175,000 | 175,000 | - | - | Employee stock option (right to buy) | |
| Lucid Diagnostics Inc | Stanley N. Lapidus | Director | Sale of securities on an exchange or to another person at price $ 1.71 per share. | 20 Sep 2022 | 17,000 | 152,320 | - | 1.7 | 29,014 | Common stock |
| Lucid Diagnostics Inc | Stanley N. Lapidus | Director | Sale of securities on an exchange or to another person at price $ 1.70 per share. | 20 Sep 2022 | 16,864 | 135,456 | - | 1.7 | 28,669 | Common stock |
| Lucid Diagnostics Inc | Stanley N. Lapidus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 59,000 | 59,000 | - | - | Employee stock option (right to buy) |